Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Facial Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global facial injectables market size reached US$ 7.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 12.2 Billion by 2027, exhibiting a growth rate (CAGR) of 9.5% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

facial injectables are administered on specific areas of the face to enhance the physical appearance of the skin. These injectables are generally made using collagen, hyaluronic acid and calcium hydroxylapatite that help restore the elasticity of the skin. They are used to reduce wrinkles, augment lips, enhance shallow contours and raise depressed scars. Currently, facial injectables are gaining traction worldwide as they are safe, cost-effective and require minimal downtime.

As collagen production and formation of fat under the skin decline with age, the skin becomes more susceptible to wrinkles and sagging. This, in confluence with the growing geriatric population and the desire to retain a young and healthy skin, represents one of the key factors bolstering the market growth. Apart from this, the escalating demand for minimally invasive surgeries, coupled with the rising trend of medical and cosmetic tourism, is contributing to the market growth. Moreover, as excessive sun exposure leads to tissue breakdown of the skin, the demand for facial injectables is escalating among outgoing individuals. Furthermore, inflating disposable incomes, the rising influence of social media, and the growing number of professional practitioners and users willing to try organic and biodegradable materials are some of the other factors influencing the market positively. Besides this, the key players are also offering customized facial injectables to provide a personalized experience to users, which, in turn, is anticipated to create a positive outlook for the market in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global facial injectables market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type, application type, application and end user.

Breakup by Product Type:

  • Collagen
  • Hyaluronic Acid (HA)
  • Botulinum Toxin Type A
  • Calcium Hydroxylapatite (CaHA)
  • Polymethylmethacrylate Beads (PMMA Microspheres)
  • Poly-L-Lactic Acid (PLLA)
  • Others
     

Breakup by Application Type:

  • Aesthetics
  • Therapeutics
     

Breakup by Application:

  • Facial Line Correction
  • Lip Augmentation
  • Face Lift
  • Acne Scar Treatment
  • Others
     

Breakup by End User:

  • Hospitals
  • Dermatology Clinics
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Allergan Plc, Anika Therapeutics Inc., Bloomage BioTechnology, Johnson & Johnson, Galderma Pharma S.A., Integra LifeSciences, Ipsen (Mayroy SA), Medytox Inc., Merz Holding GmbH & Co. KG, Prollenium Medical Technologies Inc., Sanofi, SciVision Biotech Inc., Sinclair Pharma (Huadong Medicine Co. Ltd.), Suneva Medical Inc. and Bausch Health Companies Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Product Type, Application Type, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Allergan Plc, Anika Therapeutics Inc., Bloomage BioTechnology, Johnson & Johnson, Galderma Pharma S.A., Integra LifeSciences, Ipsen (Mayroy SA), Medytox Inc., Merz Holding GmbH & Co. KG, Prollenium Medical Technologies Inc., Sanofi, SciVision Biotech Inc., Sinclair Pharma (Huadong Medicine Co. Ltd.), Suneva Medical Inc. and Bausch Health Companies Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1   Preface
2   Scope and Methodology
    2.1   Objectives of the Study
    2.2   Stakeholders
    2.3   Data Sources
        2.3.1   Primary Sources
        2.3.2   Secondary Sources
    2.4   Market Estimation
        2.4.1   Bottom-Up Approach
        2.4.2   Top-Down Approach
    2.5   Forecasting Methodology
3   Executive Summary
4   Introduction
    4.1   Overview
    4.2   Key Industry Trends
5   Global Facial Injectables Market
    5.1   Market Overview
    5.2   Market Performance
    5.3   Impact of COVID-19
    5.4   Market Forecast
6   Market Breakup by Product Type
    6.1   Collagen
        6.1.1   Market Trends
        6.1.2   Market Forecast
    6.2   Hyaluronic Acid (HA)
        6.2.1   Market Trends
        6.2.2   Market Forecast
    6.3   Botulinum Toxin Type A
        6.3.1   Market Trends
        6.3.2   Market Forecast
    6.4   Calcium Hydroxylapatite (CaHA)
        6.4.1   Market Trends
        6.4.2   Market Forecast
    6.5   Polymethylmethacrylate Beads (PMMA Microspheres)
        6.5.1   Market Trends
        6.5.2   Market Forecast
    6.6   Poly-L-Lactic Acid (PLLA)
        6.6.1   Market Trends
        6.6.2   Market Forecast
    6.7   Others
        6.7.1   Market Trends
        6.7.2   Market Forecast
7   Market Breakup by Application Type
    7.1   Aesthetics
        7.1.1   Market Trends
        7.1.2   Market Forecast
    7.2   Therapeutics
        7.2.1   Market Trends
        7.2.2   Market Forecast
8   Market Breakup by Application
    8.1   Facial Line Correction
        8.1.1   Market Trends
        8.1.2   Market Forecast
    8.2   Lip Augmentation
        8.2.1   Market Trends
        8.2.2   Market Forecast
    8.3   Face Lift
        8.3.1   Market Trends
        8.3.2   Market Forecast
    8.4   Acne Scar Treatment
        8.4.1   Market Trends
        8.4.2   Market Forecast
    8.5   Others
        8.5.1   Market Trends
        8.5.2   Market Forecast
9   Market Breakup by End User
    9.1   Hospitals
        9.1.1   Market Trends
        9.1.2   Market Forecast
    9.2   Dermatology Clinics
        9.2.1   Market Trends
        9.2.2   Market Forecast
    9.3   Others
        9.3.1   Market Trends
        9.3.2   Market Forecast
10  Market Breakup by Region
    10.1   North America
        10.1.1   United States
             10.1.1.1   Market Trends
             10.1.1.2   Market Forecast
        10.1.2   Canada
             10.1.2.1   Market Trends
             10.1.2.2   Market Forecast
    10.2   Asia-Pacific
        10.2.1   China
             10.2.1.1   Market Trends
             10.2.1.2   Market Forecast
        10.2.2   Japan
             10.2.2.1   Market Trends
             10.2.2.2   Market Forecast
        10.2.3   India
             10.2.3.1   Market Trends
             10.2.3.2   Market Forecast
        10.2.4   South Korea
             10.2.4.1   Market Trends
             10.2.4.2   Market Forecast
        10.2.5   Australia
             10.2.5.1   Market Trends
             10.2.5.2   Market Forecast
        10.2.6   Indonesia
             10.2.6.1   Market Trends
             10.2.6.2   Market Forecast
        10.2.7   Others
             10.2.7.1   Market Trends
             10.2.7.2   Market Forecast
    10.3   Europe
        10.3.1   Germany
             10.3.1.1   Market Trends
             10.3.1.2   Market Forecast
        10.3.2   France
             10.3.2.1   Market Trends
              10.3.2.2   Market Forecast
        10.3.3   United Kingdom
              10.3.3.1   Market Trends
              10.3.3.2   Market Forecast
        10.3.4   Italy
             10.3.4.1   Market Trends
             10.3.4.2   Market Forecast
        10.3.5   Spain
             10.3.5.1   Market Trends
             10.3.5.2   Market Forecast
        10.3.6   Russia
             10.3.6.1   Market Trends
             10.3.6.2   Market Forecast
        10.3.7   Others
             10.3.7.1   Market Trends
             10.3.7.2   Market Forecast
    10.4   Latin America
        10.4.1   Brazil
             10.4.1.1   Market Trends
             10.4.1.2   Market Forecast
        10.4.2   Mexico
             10.4.2.1   Market Trends
             10.4.2.2   Market Forecast
        10.4.3   Others
             10.4.3.1   Market Trends
             10.4.3.2   Market Forecast
    10.5   Middle East and Africa
        10.5.1   Market Trends
        10.5.2   Market Breakup by Country
        10.5.3   Market Forecast
11  SWOT Analysis
    11.1   Overview
    11.2   Strengths
    11.3   Weaknesses
    11.4   Opportunities
    11.5   Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis
    13.1   Overview
    13.2   Bargaining Power of Buyers
    13.3   Bargaining Power of Suppliers
    13.4   Degree of Competition
    13.5   Threat of New Entrants
    13.6   Threat of Substitutes
14  Price Analysis
15  Competitive Landscape
    15.1   Market Structure
    15.2   Key Players
    15.3   Profiles of Key Players
        15.3.1   Allergan Plc
             15.3.1.1   Company Overview
             15.3.1.2   Product Portfolio
             15.3.1.3   Financials
             15.3.1.4   SWOT Analysis
        15.3.2   Anika Therapeutics Inc.
             15.3.2.1   Company Overview
             15.3.2.2   Product Portfolio
             15.3.2.3   SWOT Analysis
        15.3.3   Bloomage BioTechnology
             15.3.3.1   Company Overview
             15.3.3.2   Product Portfolio
        15.3.4   Johnson & Johnson
             15.3.4.1   Company Overview
             15.3.4.2   Product Portfolio
             15.3.4.3   Financials
             15.3.4.4   SWOT Analysis
        15.3.5   Galderma Pharma S.A.
             15.3.5.1   Company Overview
             15.3.5.2   Product Portfolio
             15.3.5.3   SWOT Analysis
        15.3.6   Integra LifeSciences
             15.3.6.1   Company Overview
             15.3.6.2   Product Portfolio
             15.3.6.3   Financials
             15.3.6.4   SWOT Analysis
        15.3.7   Ipsen (Mayroy SA)
             15.3.7.1   Company Overview
             15.3.7.2   Product Portfolio
        15.3.8   Medytox Inc.
             15.3.8.1   Company Overview
             15.3.8.2   Product Portfolio
             15.3.8.3   Financials
        15.3.9   Merz Holding GmbH & Co. KG
             15.3.9.1   Company Overview
             15.3.9.2   Product Portfolio
             15.3.9.3   Financials
        15.3.10   Prollenium Medical Technologies Inc.
             15.3.10.1   Company Overview
             15.3.10.2   Product Portfolio
        15.3.11   Sanofi
             15.3.11.1   Company Overview
             15.3.11.2   Product Portfolio
             15.3.11.3   Financials
             15.3.11.4   SWOT Analysis
        15.3.12   SciVision Biotech Inc.
             15.3.12.1   Company Overview
             15.3.12.2   Product Portfolio
             15.3.12.3   Financials
        15.3.13   Sinclair Pharma (Huadong Medicine Co. Ltd.)
             15.3.13.1   Company Overview
             15.3.13.2   Product Portfolio
        15.3.14   Suneva Medical Inc.
             15.3.14.1   Company Overview
             15.3.14.2   Product Portfolio
        15.3.15   Bausch Health Companies Inc.
             15.3.15.1   Company Overview
             15.3.15.2   Product Portfolio
             15.3.15.3   Financials
             15.3.15.4   SWOT Analysis

List of Figures

Figure 1: Global: Facial Injectables Market: Major Drivers and Challenges
Figure 2: Global: Facial Injectables Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Facial Injectables Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Facial Injectables Market: Breakup by Product Type (in %), 2021
Figure 5: Global: Facial Injectables Market: Breakup by Application Type (in %), 2021
Figure 6: Global: Facial Injectables Market: Breakup by Application (in %), 2021
Figure 7: Global: Facial Injectables Market: Breakup by End User (in %), 2021
Figure 8: Global: Facial Injectables Market: Breakup by Region (in %), 2021
Figure 9: Global: Facial Injectables (Collagen) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Facial Injectables (Collagen) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Facial Injectables (Hyaluronic Acid) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Facial Injectables (Hyaluronic Acid) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Facial Injectables (Botulinum Toxin Type A) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Facial Injectables (Botulinum Toxin Type A) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Facial Injectables (Calcium Hydroxylapatite) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Facial Injectables (Calcium Hydroxylapatite) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Facial Injectables (Polymethylmethacrylate Beads) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Facial Injectables (Polymethylmethacrylate Beads) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Facial Injectables (Poly-L-Lactic Acid) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Facial Injectables (Poly-L-Lactic Acid) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Facial Injectables (Other Product Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Facial Injectables (Other Product Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Facial Injectables (Aesthetics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Facial Injectables (Aesthetics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Facial Injectables (Therapeutics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Facial Injectables (Therapeutics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Facial Injectables (Facial Line Correction) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Facial Injectables (Facial Line Correction) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Facial Injectables (Lip Augmentation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Facial Injectables (Lip Augmentation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Facial Injectables (Face Lift) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Facial Injectables (Face Lift) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Facial Injectables (Acne Scar Treatment) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Facial Injectables (Acne Scar Treatment) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Facial Injectables (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Facial Injectables (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Facial Injectables (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Facial Injectables (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Global: Facial Injectables (Dermatology Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Global: Facial Injectables (Dermatology Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Global: Facial Injectables (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Global: Facial Injectables (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: North America: Facial Injectables Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: North America: Facial Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: United States: Facial Injectables Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: United States: Facial Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Canada: Facial Injectables Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Canada: Facial Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Asia-Pacific: Facial Injectables Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Asia-Pacific: Facial Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: China: Facial Injectables Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: China: Facial Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Japan: Facial Injectables Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Japan: Facial Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: India: Facial Injectables Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: India: Facial Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: South Korea: Facial Injectables Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: South Korea: Facial Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Australia: Facial Injectables Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Australia: Facial Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Indonesia: Facial Injectables Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Indonesia: Facial Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Others: Facial Injectables Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Others: Facial Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Europe: Facial Injectables Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Europe: Facial Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Germany: Facial Injectables Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Germany: Facial Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: France: Facial Injectables Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: France: Facial Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: United Kingdom: Facial Injectables Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: United Kingdom: Facial Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Italy: Facial Injectables Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Italy: Facial Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Spain: Facial Injectables Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Spain: Facial Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Russia: Facial Injectables Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Russia: Facial Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Others: Facial Injectables Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Others: Facial Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Latin America: Facial Injectables Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Latin America: Facial Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Brazil: Facial Injectables Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Brazil: Facial Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Mexico: Facial Injectables Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Mexico: Facial Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Others: Facial Injectables Market: Sales Value (in Million US$), 2016 & 2021
Figure 88: Others: Facial Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Middle East and Africa: Facial Injectables Market: Sales Value (in Million US$), 2016 & 2021
Figure 90: Middle East and Africa: Facial Injectables Market: Breakup by Country (in %), 2021
Figure 91: Middle East and Africa: Facial Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 92: Global: Facial Injectables Industry: SWOT Analysis
Figure 93: Global: Facial Injectables Industry: Value Chain Analysis
Figure 94: Global: Facial Injectables Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Facial Injectables Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Facial Injectables Market Forecast: Breakup by Product Type (in Million US$), 2022-2027
Table 3: Global: Facial Injectables Market Forecast: Breakup by Application Type (in Million US$), 2022-2027
Table 4: Global: Facial Injectables Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 5: Global: Facial Injectables Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 6: Global: Facial Injectables Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Facial Injectables Market Structure
Table 8: Global: Facial Injectables Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

According to the estimates by IMARC Group, the global facial injectables market is expected to witness a CAGR of 9.5% from 2022 to 2027.

The expanding cosmetic surgery sector with the rising consumer consciousness towards physical appearances represents one of the key drivers for the global facial injectables market.

The emergence of minimally- or non-invasive cosmetic surgeries along with the increasing demand for organic and biodegradable product variants account for some of the key industry trends in the global facial injectables market.

Sudden outbreak of the COVID-19 pandemic had led to the cancellation or postponement of several elective cosmetic surgeries to mitigate the risk of coronavirus infection upon clinic visits that had adversely impacted the market for facial injectables.

On the basis of the product type, the market has been bifurcated into collagen, Hyaluronic Acid (HA), Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Polymethylmethacrylate Beads (PMMA Microspheres), Poly-L-Lactic acid (PLLA), and others. Currently, Botulinum Toxin Type A holds the majority of the total market share.

Based on the application type, the market has been segmented into aesthetics and therapeutics. Amongst these, aesthetics represent the largest segment.

On the basis of the end user, the market has been bifurcated into hospitals, dermatology clinics, and others. Among these, hospitals hold the largest market share.

Region-wise, the market has been classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America, where North America dominates the global market.

The key companies in the global facial injectables market are Allergan Plc, Anika Therapeutics Inc., Bloomage BioTechnology, Johnson & Johnson, Galderma Pharma S.A., Integra LifeSciences, Ipsen (Mayroy SA), Medytox Inc., Merz Holding GmbH & Co. KG, Prollenium Medical Technologies Inc., Sanofi, SciVision Biotech Inc., Sinclair Pharma (Huadong Medicine Co. Ltd.), Suneva Medical Inc., and Bausch Health Companies Inc.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Related Report

Peripheral Vascular Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Vascular Grafts Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Operating Room Equipment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Intraoperative Neuromonitoring (IONM) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Neurology Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )

Drop us an email at

sales@imarcgroup.com

Social Links